So at a time when they are restructuring and cutting costs (like many investment groups) they are still willing to put money into HAZ. I cant see how this weakens the point.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
